Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice
Aline David-Silva,1 João Victor Esteves,1 Mychel Raony PT Morais,2 Helayne Soares Freitas,1 Telma Maria Zorn,2 Maria Lucia Correa-Giannella,3 Ubiratan Fabres Machado1 1Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São Paulo, S&atil...
Main Authors: | David-Silva A, Esteves JV, Morais MRPT, Freitas HS, Zorn TM, Correa-Giannella ML, Machado UF |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-03-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/dual-sglt1sglt2-inhibitor-phlorizin-ameliorates-non-alcoholic-fatty-li-peer-reviewed-article-DMSO |
Similar Items
-
Effects of Salvia mirzayanii extract administration on hyperglycemia improvement in diabetic rats: The role of GLUT4, PEPCK and G6Pase genes
by: Rahman Mahdizadehdehosta, et al.
Published: (2024-02-01) -
Evaluation of the binding affinity and antioxidant activity of phlorizin to pepsin and trypsin
by: Jing Zhang, et al.
Published: (2024-01-01) -
Phlorizin, an Important Glucoside: Research Progress on Its Biological Activity and Mechanism
by: Tongjia Ni, et al.
Published: (2024-02-01) -
Effects of Phloretin and Phlorizin on Glutamate-Induced Neuron Injury: in Vitro Study
by: Damla BİNNETOĞLU, et al.
Published: (2019-12-01) -
Metabolomics Insights of the Immunomodulatory Activities of Phlorizin and Phloretin on Human THP-1 Macrophages
by: Noelia Cambeiro-Pérez, et al.
Published: (2021-02-01)